Compugen (CGEN) EBT Margin (2009 - 2026)

Compugen (CGEN) reported EBT Margin of 352.21% for Q1 2026, up 3916.0% on a YoY basis from 8.77% in Q1 2025, and up 317.18% sequentially from 84.42% in Q4 2025.

Compugen (CGEN) EBT Margin (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 14 years of EBT Margin data on file, last reported at 352.21% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 3916.0% year-over-year to 352.21%; the trailing twelve-month figure through Mar 2026 stood at 49.43% (up 8503.0% YoY), and the FY2025 full-year result was 48.65%, up 8349.0% from the prior year.
  • EBT Margin rose to 352.21% in Q1 2026, from 84.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 352.21% in Q1 2026 to a low of 1723.07% in Q2 2025.
  • A 5-year average of 151.92% and a median of 33.74% in 2024 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 49999 bps in 2025, while the deepest fall reached 147479 bps in 2025.
  • Tracing CGEN's EBT Margin over 5 years: stood at 40.45% in 2022, then jumped by 238 bps to 55.95% in 2023, then plunged by 843 bps to 415.57% in 2024, then surged by 120 bps to 84.42% in 2025, then surged by 317 bps to 352.21% in 2026.
  • Business Quant data shows CGEN's EBT Margin at 352.21% in Q1 2026, 84.42% in Q4 2025, and 366.95% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 352.21%

Historic Data

Download Data
DateValue
Mar 31, 2026 352.21%
Dec 31, 2025 84.42%
Sep 30, 2025 -366.95%
Jun 30, 2025 -1,723.07%
Mar 31, 2025 313.05%
Dec 31, 2024 -415.57%
Sep 30, 2024 33.74%
Jun 30, 2024 -248.28%
Mar 31, 2024 283.86%
Dec 31, 2023 55.95%
Dec 31, 2022 -40.45%
Dec 31, 2020 -428.15%
Sep 30, 2018 -39.88%
Dec 31, 2016 -16,022.64%
Sep 30, 2016 -11,115.71%
Jun 30, 2016 -1,333.06%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -0.99%
Sep 30, 2015 -2,944.10%
Jun 30, 2015 -3,052.91%